Hereditary interstitial kidney disease

Seminars in Nephrology

Volumn 30, Issue 4, 2010, Pages 366-373

  Bleyer, Anthony J ^a   Hart, P Suzanne ^b   Kmoch, Stanislav ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c Charles University in Prague and General University Hospital in Prague   (Czech Republic)

Author keywords

Hereditary interstitial kidney disease; Medullary cystic kidney disease; Renin; Review; Uromodulin

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; FLUDROCORTISONE; HEMOGLOBIN; LOSARTAN; NONSTEROID ANTIINFLAMMATORY AGENT; RENIN; TAMM HORSFALL GLYCOPROTEIN; URIC ACID;

ANEMIA; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 1; CHROMOSOME IDENTIFICATION; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DIAGNOSTIC VALUE; GENETIC ANALYSIS; GENETIC CODE; GENETIC LINKAGE; GOUT; HEREDITARY INTERSTITIAL KIDNEY DISEASE; HUMAN; HYPERKALEMIA; HYPERURICEMIA; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MEDULLARY SPONGE KIDNEY; MUTATIONAL ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; URINE SEDIMENT;

ALGORITHMS; GOUT; HUMANS; KIDNEY DISEASES, CYSTIC; NEPHRITIS, INTERSTITIAL; PEDIGREE; RENIN; UROMODULIN;

EID: 77956136546     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2010.06.003     Document Type: Article

References (20)

1. Hildebrandt F., Omram H. New insights: nephronophthisis-medullary cystic kidney disease. Pediatr Nephrol 2001, 16:168-176.
2. Serafini-Cessi F., Malagolini N., Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 2003, 42:658-676.
3. Hoyer J.R., Sisson S.P., Vernier R.L. Tamm-Horsfall glycoprotein ultrastructural immunoperoxidase localization in rat kidney. Lab Invest 1979, 41:168-173.
4. Malagolini N., Cavallone D., Serafini-Cessi F. Intracellular transport, cell-surface exposure and release of recombinant Tamm-Horsfall glycoprotein. Kidney Int 1997, 52:1340-1350.
5. Raffi H.S., Bates J.M., Laszik Z., Kumar S. Tamm-Horsfall protein protects against urinary tract infection by proteus mirabilis. J Vasc Surg 2009, 181:2332-2338.
6. Hart T.C., Gorry M.C., Hart P.S., Woodard A.S., Shihabi Z., Sandhu J., et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 2002, 39:882-892.
7. Rampoldi L., Caridi G., Santon D., Boaretto F., Bernascone I., Lamorte G., et al. Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. Hum Mol Genet 2003, 12:3369-3384.
8. Choi S.W., Ryu O.H., Choi S.J., Song I.S., Bleyer A.J., Hart T.C. Mutant Tamm-Horsfall glycoprotein accumulation in the endoplasmic reticulum induces apoptosis that is reversed by colchicine and sodium 4-phenylbutyrate. J Am Soc Nephrol 2005, 16:3006-3014.
9. Vylet'al P., Kubiova M., Kalbacova M., Hodanvoa K., Baresova V., Stiburkova B., et al. Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Kidney Int 2006, 70:1155-1169.
10. Bleyer A.J., Hart T.C., Shihabi Z., Robins V., Hoyer J.R. Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein. Kidney Int 2004, 66:974-977.
11. Bleyer A.J., Woodard A.S., Shihabi Z., Sandhu J., Zhu H., Satko S.G., et al. Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene. Kidney Int 2003, 64:36-42.
12. Neumann H.P.H., Zauner I., Strahm B., Bender B.U., Schollmeyer P., Blum U., et al. Late occurrence of cysts in autosomal dominant medullary cystic kidney disease. Nephrol Dial Transplant 1997, 12:1242-1246.
13. Eieselbach R.E., Steele T.H. Intrinsic renal disease leading to abnormal urate excretion. Nephron 1975, 14:81-87.
14. Wolf M.T.F., Mucha B.E., Attanasio M., Zalewski I., Karle S.M., Neumann H.P.H., et al. Mutations of the Uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains. Kidney Int 2003, 64:1580-1587.
15. McBride M.B., Simmonds H.A., Ogg C.S., Cameron J.S., Rigden C.S., Rees L., et al. Efficacy of Allopurinol in ameliorating the progressive renal disease in familial juvenile hyperuricaemic nephropathy (FJHN): a six-year update. Purine and pyrimidine metabolism in man IX 1998, 7-11. Plenum Press, New York. E.A. Griesmacher (Ed.).
16. Moro F., Simmonds H.A., Cameron J.S., Ogg C.S., Williams G.D., McBride M.B., et al. Does allopurinol affect the progression of familial juvenile gouty nephropathy?. Purine and pyrimidine metabolism in man VII 1991, 199-202. Plenum Press, New York. R.A. Harkness (Ed.).
17. Hamada T., Ichida K., Hosoyamada M., Mizuta E., Yanagihara K., Sonoyama K., et al. Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients. Am J Hypertens 2008, 21:1157-1162.
18. Zivna M., Hulkova H., Marignon M., Hodanova K., Vylet'al P., Kalbacova M., et al. Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. Am J Human Genet 2009, 85:204-213.
19. Stavrou C., Koptides M., Tombazos C., Psara E., Patsias C., Zouvani I., et al. Autosomal-dominant medullary cystic kidney disease type 1: clinical and molecular findings in six large Cypriot families. Kidney Int 2002, 62:1385-1394.
20. Wolf M.T.F., Mucha B.E., Hennies H.C., Attanasio M., Panther F., Zalewski I., et al. Medullary cystic kidney disease type 1: mutational analysis in 37 genes based on haplotype sharing. Hum Genet 2006, 119:649-658.